APA (7th ed.) Citation

Hobbs, F. D. R., Yu, L., Saville, B. R., Bafadhel, M., & Butler, C. C. (2021). High-dose budesonide for early COVID-19 - Authors' reply. Lancet, 398(10317), 2147. https://doi.org/10.1016/S0140-6736(21)02449-1

Chicago Style (17th ed.) Citation

Hobbs, F D Richard, Ly-Mee Yu, Benjamin R. Saville, Mona Bafadhel, and Christopher C. Butler. "High-dose Budesonide for Early COVID-19 - Authors' Reply." Lancet 398, no. 10317 (2021): 2147. https://doi.org/10.1016/S0140-6736(21)02449-1.

MLA (9th ed.) Citation

Hobbs, F D Richard, et al. "High-dose Budesonide for Early COVID-19 - Authors' Reply." Lancet, vol. 398, no. 10317, 2021, p. 2147, https://doi.org/10.1016/S0140-6736(21)02449-1.